Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program

2006 ◽  
Vol 79 (2) ◽  
pp. 138-143 ◽  
Author(s):  
Fu-Hsiung Su ◽  
Jong-Dar Chen ◽  
Shu-Hsing Cheng ◽  
Ching-Hung Lin ◽  
Yi-Hui Liu ◽  
...  
1984 ◽  
Vol 48 (10) ◽  
pp. 563-565
Author(s):  
HJ Kwon ◽  
KM Keenan ◽  
H Colman ◽  
KM Sundeen ◽  
DE Waite

1985 ◽  
Vol 6 (8) ◽  
pp. 306-309 ◽  
Author(s):  
Linda J. Hanacik ◽  
Timothy R. Franson ◽  
Jill D. Gollup ◽  
Michael W. Rytel

AbstractHealth care personnel with frequent blood contact are at high risk for being exposed to and developing hepatitis B infection. Exposure to unidentified infectious patients may lead to personnel inadvertently foregoing appropriate, passive immunoprophylaxis. For these reasons, our hospital elected to conduct an aggressive program to administer hepatitis B vaccine to all employees at high risk for exposure to hepatitis B virus, thus protecting such employees from inadvertent occupational exposure. Administrators agreed to offer the vaccine as a free employee health benefit. “High-risk” employees attended mandatory inservice presentations covering hepatitis B disease, vaccine safety and efficacy, and related concerns. High-risk individuals were required to either receive vaccine or sign “informed refusal” forms. The vaccine clinic was organized to accommodate employee work schedules. Of high-risk employees eligible for vaccination, 90% completed a three-dose vaccine course. Extensive inservice education, financial and administrative support, and careful advance planning are all crucial in achieving high compliance with vaccination programs. A description of key steps in designing a successful vaccination program is outlined.


2007 ◽  
Vol 34 (9) ◽  
pp. 663-668 ◽  
Author(s):  
Robert A. Gunn ◽  
Marjorie A. Lee ◽  
Paula J. Murray ◽  
Robert A. Gilchick ◽  
Harold S. Margolis

2021 ◽  
Vol 48 (2) ◽  
pp. 62-65
Author(s):  
O.A. Adeoye ◽  
O. Oniyangi ◽  
I.A. Ojuawo

Background: Human immunodeficiency virus infection remains a global pandemic. Co infection with hepatitis B virus leads to rapid progression to AIDS if not diagnosed and promptly treated or better still prevented. The study aims at determining the prevalence and risk factors of hepatitis B infection in HIV infected children being followed up at the Paediatric HIV clinic. Patients and methods: A cross-sectional study of 261 HIV infected children aged eight months to fourteen years to determine the prevalence of Hepatitis B infection and pattern of hepatitis B vaccination was carried out between July and October 2012 at the Paediatric HIV clinic of National Hospital Abuja. Ethical approval was obtained from Ethical Committee of the hospital. Vaccination and transfusion history were obtained from the parents and guardians of the subjects using a proforma after signed informed consent. Blood samples were collected for Hepatitis B surface antigen screening and Hepatitis B screening in those with HBsAg positive blood samples. Results: Only 3 (1.15%) of the 261 HIV infected children had Hepatitis B infection. All the children less than 5 years old in this cohort received hepatitis B vaccination and none of them had Hepatitis B infection. The HIV/HBV co infected children were older than ten years (p = 0.047) and history of blood transfusion (p = 0.003) was also significant. However, scarification (p = 0.996), local circumcision (p = 0.928); uvulectomy (p = 0.898) were not significant risk factors in this cohort. Conclusion: There is need to intensify routine hepatitis B vaccination and routine screening of blood before necessary transfusion. This would further lead to a low prevalence of Hepatitis B in HIV infected children and the general populace at large.


2007 ◽  
Vol 106 (7) ◽  
pp. 513-519 ◽  
Author(s):  
Hsien-Cheng Chang ◽  
Chung-Jen Yen ◽  
Yi-Chin Lee ◽  
Tai-Yuan Chiu ◽  
Chyi-Feng Jan

2016 ◽  
Vol 88 (9) ◽  
pp. 1567-1575 ◽  
Author(s):  
Nahed A. Makhlouf ◽  
Ahlam M. Farghaly ◽  
Saad Zaky ◽  
Hebat-Alla G. Rashed ◽  
Nagla H. Abu Faddan ◽  
...  

2018 ◽  
Vol 13 (1) ◽  
pp. 5-11
Author(s):  
Purusotam Raj Shedain ◽  
Gehanath Baral ◽  
Basant Maharjan

Background: Disparity in health care service and disease prevalence are global issues. Hepatitis B infection is a global public health problem; its prevalence is ubiquitous and heterogeneous.This article reviews the situation and an impact of hepatitis B infection in the indigenous people in Nepal through the lens of equity perspective.Methods: Literature search and collection of information from different sources.Results: Hepatitis B prevalence is low (0.9%) at the country level in Nepal but higher, up to 38%, among the indigenous population compared to the national prevalence. Those who live in the high endemic areas are at risk of getting the infection from both vertical and horizontal mode of transmission. The unvaccinated cohort of infant (0-11 months) between 2003 and 2016 has swollen, 2764362 in number or 29 % of the total cohort. The National Immunization Program (NIP) administered hepatitis B vaccination at 6 weeks of birth, considering the low prevalence at the national level. The NIP does not prevent perinatal transmission of the infection. The mother to child transmission of the infection often leads to chronic liver diseases and about 20–30% of adults who are chronically infected will develop cirrhosis and/or liver cancer. The indigenous populations are thus disproportionately affected by the infection.Conclusions: The policy update is required to implement the hepatitis B vaccination at birth or within 24 hours in high endemic setting along with a comprehensive package to reduce the disparity, prevent the transmission, risk of chronic infection and its sequelae to achieve the national goal and international commitment on the sustainable development goal by 2030.


Sign in / Sign up

Export Citation Format

Share Document